Enhancing Stem Cell Therapy for Type 2 Diabetes by Targeting Adra2α Expression
Research indicates that Adra2α expression affects the regenerative potential of adipose-derived stem cells (ASCs) in type 2 diabetes. Suppressing this receptor in ASCs improves their therapeutic impact by enhancing cell proliferation, migration, and growth factor secretion.
